oncologische aandoeningen advanced cancer cancer
Conditions
Interventions
The face-to-face intervention: FOCUS+
Delivery mode and dose
This intervention will be provided to patient-caregiver dyads after they
completed the baseline measurement (T0) and were randomly allocat
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: The study population will consist of patients with advanced solid organ cancer (except brain cancer) and their primary family caregiver. Inclusion criteria Patient Diagnosis of cancer: solid organ (lung, colorectal, breast, prostate and other) No longer receives curative treatment (only life-prolonging or palliative treatments) Written informed consent Lives within 100 km for intervention nurses to travel Family caregiver Written informed consent Primary informal caregiver as determined by the patient Lives within 100 km for intervention nurses to travel Dyad Patient and/or family caregivers has access to and is familiar with use of internet
Exclusion criteria
Exclusion criteria: Exclusion criteria Brain cancer, brain metastases, non-solid cancers Prognosis of less than 3 months Has no informal caregivers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoints are emotional functioning and self-efficacy of both the person with advanced cancer and the family caregiver at t1. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoints are: quality of life of the patient and caregiver, benefits of illness, coping, dyadic communication, ways of giving support at t1. All listed primary and secondary outcomes at t2 and formal healthcare use and costs at t1 and t2 | — |
Countries
Netherlands
Outcome results
None listed